Home » Topics » BioWorld Science

BioWorld Science
RSS

Positive topline results presented for phase II study of Gazyva in lupus nephritis

June 11, 2019

FDA approves first chemoimmunotherapy regimen for patients with DLBCL

June 11, 2019

Northwestern University presents GBA activators

June 11, 2019

Homology Medicines initiates phase I/II study for HMI-102 gene therapy for adults with PKU

June 11, 2019

Merck & Co. synthesizes new IDO1 inhibitors

June 11, 2019

Hepagene Therapeutics identifies MAP3K5 inhibitors

June 11, 2019

Harvard College and Eisai divulge new compounds for cancer

June 11, 2019

Topline data presented from phase II study of NYX-2925 in patients with fibromyalgia

June 11, 2019

Innovate Biopharmaceuticals initiates first ever phase III study in celiac disease

June 11, 2019

Arvinas patents new IRAK-4-targeting compounds

June 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...